Pharma-Bio Serv Inc. logo

Pharma-Bio Serv Inc. (PBSV)

Market Closed
11 Aug, 20:00
OTCQB OTCQB
$
0. 54
+0.12
+28.5476%
$
13.28M Market Cap
26.67 P/E Ratio
- Div Yield
1,000 Volume
0.08 Eps
$ 0.42
Previous Close
Add Transaction
Day Range
0.54 0.54
Year Range
0.42 1.36
Want to track PBSV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PBSV closed today higher at $0.54, an increase of 28.5476% from yesterday's close, completing a monthly decrease of -5.2807% or -$0.03. Over the past 12 months, PBSV stock lost -10.0167%.
PBSV pays dividends to its shareholders, with the most recent payment made on Mar 20, 2026. The next estimated payment will be in In 7 months on Mar 20, 2027 for a total of $0.075.
The last earnings report, released on Mar 16, 2026, missed the consensus estimates by -0.02%. On average, the company has fell short of earnings expectations by -0.0233%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

PBSV Chart

People also search for

QDM International Inc.
$ 5
0%
Quaint Oak Bancorp Inc.
$ 14.5
+0.346%
Farmers Bank of Appomattox
$ 31.75
-2.6074%
PFS Bancorp Inc.
$ 20.31
+0.0493%
CareView Communications Inc.
$ 0.05
-2%
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024

DORADO, PUERTO RICO / ACCESSWIRE / September 16, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and nine months ended July 31, 2024 were approximately $2.4 million and $7.2 million, respectively, a decrease of approximately $2.2 million and $6.2 million, respectively, when compared to the same periods last year. Net loss for the three and nine months ended July 31, 2024 were approximately $0.3 million and $0.8 million, respectively, compared to the same periods last year to a net income of approximately $0.5 million and $1.4 million, respectively.

Accesswire | 1 year ago
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024

Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024

DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and six months ended April 30, 2024 were approximately $2.4 and $4.8, million, respectively, a decrease of approximately $2.2 and $4.0 million when compared to the same periods last year. Net loss for the three and six months ended April 30, 2024 were approximately $0.2 and $0.5 million, respectively, compared to the same periods last year to a net income of approximately $0.4 and $0.8 million, respectively.

Accesswire | 2 years ago

Pharma-Bio Serv Inc. (PBSV) FAQ

What is the stock price today?

The current price is $0.54.

On which exchange is it traded?

Pharma-Bio Serv Inc. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is PBSV.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 13.28M.

Has Pharma-Bio Serv Inc. ever had a stock split?

No, there has never been a stock split.

Pharma-Bio Serv Inc. Profile

Insurance Industry
Financials Sector
Victor Sanchez CEO
OTCQB Exchange
71711N100 CUSIP
PR Country
55 Employees
27 Feb 2026 Last Dividend
- Last Split
- IPO Date

Overview

Pharma-Bio Serv, Inc. is an established compliance and technology transfer services consulting firm that has been operating since 1993. With a broad geographical footprint, the company offers its specialized services not only in its home base of Puerto Rico but also across the United States, Europe, Brazil, and other international locations. Positioned to serve a diverse range of sectors, including pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, and food industries, Pharma-Bio Serv is dedicated to ensuring its clients meet stringent regulatory standards. Its corporate headquarters are strategically situated in Dorado, Puerto Rico, reinforcing its strong presence within and outside the United States.

Products and Services

  • Regulatory Compliance
  • This service is critical for companies looking to navigate the complex landscape of regulatory requirements. Pharma-Bio Serv Inc. assists clients in ensuring all aspects of their operation are compliant with the relevant local, national, and international regulatory standards. This is vital for businesses aiming to maintain their licenses to operate, avoid legal issues, and uphold the highest levels of safety and quality in their processes and products.

  • Validation
  • Validation services are essential for affirming that equipment, systems, and processes perform consistently according to their intended use. Pharma-Bio Serv Inc. offers comprehensive validation services that cover equipment qualification, process validation, and cleaning validation, thereby ensuring that products meet all required standards and specifications for quality and safety.

  • Technology Transfer
  • This service involves the systematic transfer of technology, processes, and methodologies between development and production, or between manufacturing sites. Pharma-Bio Serv Inc. facilitates seamless technology transfer through careful planning, documentation, and execution, ensuring that knowledge is accurately transferred and applied to achieve consistent product quality.

  • Engineering and Project Management
  • The company provides engineering and project management services to support the design, development, and implementation of projects within the regulated industries. From conceptual design through to final validation, Pharma-Bio Serv Inc. ensures projects are completed on time, within budget, and in compliance with all regulatory requirements. This comprehensive approach helps clients to streamline operations, enhance productivity, and accelerate time to market for their products.

  • Process Support
  • Pharma-Bio Serv Inc. offers process support services that aim to optimize manufacturing processes, improve efficiency, and ensure continuous compliance with industry regulations. This includes troubleshooting process issues, implementing process improvements, and providing ongoing support to maintain operational excellence.

Contact Information

Address: PO Box 1049
Phone: 787 278 2709